The Clinical Efficacy and Safety of SGLT2 Inhibitors in Japanese Patients with Type 2 Diabetes for Two Years

被引：0
|
作者：
Tosaki, Takahiro
Kamiya, Hideki
Inagaki, Akemi
Kondo, Masaki
Nagao, Eriko
Yamada, Yuichiro
Kato, Yoshiro
Tsunekawa, Shin
Himeno, Tatsuhito
Hayasaki, Tomoyo
Sato, Shiori
Nakaya, Yuki
Nakamura, Jiro
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2420-PUB
引用
收藏
页码：A631 / A631
页数：1
相关论文
共 50 条
  • [21] Systematic review and meta-analysis of the efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus
    Tsapas, A.
    Vassilakou, D.
    Athanasiadou, E.
    Karagiannis, T.
    Matthews, D. R.
    DIABETOLOGIA, 2012, 55 : S107 - S107
  • [22] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [23] SGLT2 inhibitors in the management of type 2 diabetes
    R. P. Monica Reddy
    Silvio E. Inzucchi
    Endocrine, 2016, 53 : 364 - 372
  • [24] SGLT2 inhibitors in the management of type 2 diabetes
    Reddy, R. P. Monica
    Inzucchi, Silvio E.
    ENDOCRINE, 2016, 53 (02) : 364 - 372
  • [25] Effects of SGLT2 inhibitors on the intestinal bacterial flora in Japanese patients with type 2 diabetes mellitus
    Kusunoki, Masataka
    Hisano, Fumiya
    Matsuda, Shin-ichi
    Kusunoki, Akiko
    Wakazono, Naomi
    Tsutsumi, Kazuhiko
    Miyata, Tetsuro
    DRUG RESEARCH, 2023, 73 (07) : 412 - 416
  • [26] Relationship between the Effect of SGLT2 Inhibitors and Dietary Intake in Japanese Patients with Type 2 Diabetes
    Kabasawa, Hideyuki
    Hosojima, Michihiro
    Murayama, Toshiko
    Tanaka, Takahiro
    Kuwahara, Shoji
    Kaseda, Ryohei
    Suzuki, Yoshiki
    Narita, Ichiei
    Saito, Akihiko
    DIABETES, 2019, 68
  • [27] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
  • [28] Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes
    Su, Hsuan-Yu
    Yang, Chen-Yi
    Lee, Yu-Hsuan
    Su, Pei-Fang
    Liu, Yi-Chia
    Ou, Huang-Tz
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [29] Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes
    Mannucci, Edoardo
    Mangia, Pier Paolo
    Pradelli, Lorenzo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2020, 21 : 3 - 20
  • [30] Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus
    Takahashi, Hiroshi
    Suganuma, Yuka
    Ohno, Takayuki
    Nishimura, Rimei
    DIABETOLOGY INTERNATIONAL, 2022, 13 (04) : 606 - 614
12345